The symptomatic and clinical expression of psychiatric disorders in children and adolescents is strongly influenced by the cultural setting they are growing up in. These cultural variations complicate psychiatric care, especially for migrant children, for whom appropriate care must be designed. Transcultural psychotherapy is an original psychotherapeutic technique developed to meet these specific requirements in France and in different European and American countries. Its theoretical and methodological foundations rest on the works of George Devereux in ethnopsychiatry (1970). A psychotherapeutic technique intended for first-generation migrants was developed by Tobie Nathan and coll (1986). Marie-Rose Moro and colleagues (1990) have adapted this technique to second-generation migrants. Indicated as a second-line treatment after the failure of standard management, this technique is fully formalized today. It comprises group consultations for the child and the family as a one-hour session each month, directed by a principal therapist, assisted by a group of co-therapists (of diverse cultural origins and occupations) and an interpreter in the family's mother tongue. The concept of culture is used to establish the therapeutic alliance, decode the symptoms, and propose treatment. The children and adolescents receiving this treatment have varied psychopathological profiles, mostly involving depressive and/or anxiety disorders. Specifically, migrants' children are especially vulnerable to depression, their psychiatric care is generally longer and less effective than in the general population, and their rate of treatment failure higher. Transcultural psychotherapy has demonstrated its value in these situations in numerous qualitative studies, but its efficacy has not yet been assessed by a method providing a high level of evidence, such as randomized controlled trials.
Mixed method study using a multicenter, Bayesian randomized clinical trial with blinded evaluation of the primary outcome. Two parallel groups of 40 children or adolescents from 6 to 20 years-old and their family will be included. In the experimental group, patients will attend six sessions of transcultural therapy in addition to usual care. The improved Clinical Global Impression scale scores at 6 months will be compared across groups. Qualitative analysis of families and therapists' interviews will allow to specify the therapeutic processes and acceptability of the therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
80
In addition to usual care, the participants receive transcultural psychotherapy
Service de Psychopathologie de l'enfant, de l'adolescent, CHU Avicenne
Bobigny, France
Service de psychiatrie de l'enfant et de l'adolescent, CHRU Gabriel Montpied
Clermont-Ferrand, France
Maison de Solenn, Cochin Hospital
Paris, France
Centre Médico-psychologique, Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital La Grave, CHU Toulouse
Toulouse, France
Severity Score on the Improved Global Impression Scale (iCGI) to assess remission
.iCGI score is a scale ranging from 1 to 7, 1 being Normal, not at all ill, and 7 - Among the most extremely ill patients. 1. \- Normal, not at all ill 2. \- Borderline mentally ill 3. \- Mildly ill 4. \- Moderately ill 5. \- Markedly ill 6. \- Severely ill 7. \- Among the most extremely ill patients Remission is defined as a mean iCGI score over the 3 experts \<4 at 28 weeks of treatment (W34).
Time frame: at week 34 visit (v5)
Severity score on the iCGI
To compare the course of the severity of depression in each group over the first 34 weeks after inclusion
Time frame: at baseline and weeks 6, 13, 20, 27 and 34 and 52
Score on the French version of the Children's Depression Rating Scale-Revised (CDRS-R)
It's a 17-item scale with answers on 5 or 7-point Likert scale (total score ranges from 17 to 113). A score ≥ 40 is indicative of depression, whereas a score ≤28 is often used to define remission. To compare the course of the level of depressive symptoms in each group over the first 34 weeks after inclusion
Time frame: at baseline and weeks 6, 13, 20, 27 and 34 and 52
Score on the French version of the State-Trait Anxiety Inventory for children (STAI-C)
To compare the course of the level of anxiety symptoms in each group over the first 34 weeks after inclusion
Time frame: at baseline and weeks 6, 13, 20, 27 and 34 and 52
Score changes in Depression and anxiety Scores between Week 34 and week 52
To evaluate the persistence of the efficacy of transcultural psychiatry over time by describing the course of the severity of the depression and of the depressive and anxiety symptoms from 34 to 52 weeks after inclusion in the group of patients treated by transcultural psychotherapy during the first 34 weeks
Time frame: at 34 and 52 weeks
analysis of the content of the clinical data collected during the visits
To describe the therapeutic processes that enabled the improvement of patients treated by transcultural psychotherapy
Time frame: between 34 and 44 weeks
analysis of the content of the interview with the families and therapists at the end of the treatment
For this secondary objective concerning the group of patients treated by transcultural psychotherapy, a qualitative design will be used to explore the perceived efficacity and acceptability of the therapy. Investigators will organize two semi-structured interviews after the fifth therapy session. These semi-structured interviews will be conducted by a psychologist trained in transcultural care. One interview will concern the family and will explore, with the help of an interpreter speaking the native language of the family, the acceptability of the care as well as success factors identified by the family. The other interview will concern the therapists and will explore the success factors identified by the professionals. The interviews guides have been constructed by specialists of transcultural care in childhood and adolescence To describe the perceived efficacy and acceptability of the transcultural psychotherapy for the patient and the family
Time frame: between 34 and 44 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.